Edwards Lifesciences Corporation logo
EWEdwards Lifesciences Corporation

Is the earnings yield high or low?

The earnings yield of 2.07% is 48% below its 5-year average of 3.98%, near the low end of its 5-year range (1.21%–10.54%).

As of Sunday, June 28, 2026. 57.26% below its 12-month average of 4.84%.

P/E Ratio|FCF Yield|Dividend Yield|All Metrics
EW Earnings Yield

EW Earnings Yield Chart

2.07%
-77.18% 1Y
EW Earnings Yield

EW Average Earnings Yield Chart

EW Earnings Yield

EW Current vs Average Earnings Yield Chart

EW Earnings Yield Metrics

EARNINGS YIELD

2.07%

EARNINGS YIELD AVG TTM

4.84%

EARNINGS YIELD AVG 3Y

5.01%

EARNINGS YIELD AVG 5Y

2.65%

EARNINGS YIELD AVG 10Y

2.36%

EARNINGS YIELD AVG 15Y

2.50%

EARNINGS YIELD AVG 20Y

3.02%

CURRENT VS TTM AVG

-57.26%

CURRENT VS 3Y AVG

-58.67%

CURRENT VS 5Y AVG

-21.86%

CURRENT VS 10Y AVG

-12.23%

CURRENT VS 15Y AVG

-17.29%

CURRENT VS 20Y AVG

-31.39%

EW Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
Edwards Lifesciences Corporation (EW)$52.27B2.07%4.84%5.01%2.65%
Cencora, Inc. (COR)vs ›$55.67B4.56%3.02%3.50%4.16%
Cardinal Health, Inc. (CAH)vs ›$55.72B2.75%3.54%2.96%3.43%
Becton, Dickinson and Company (BDX)vs ›$56.49B2.53%3.61%3.08%3.08%
Humana Inc. (HUM)vs ›$46.08B2.44%4.61%4.82%4.82%
IDEXX Laboratories, Inc. (IDXX)vs ›$43.50B2.46%2.03%2.08%1.95%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›$65.20B6.49%6.19%5.15%6.37%
Boston Scientific Corporation (BSX)vs ›$65.74B5.38%2.51%1.75%1.52%
Agilent Technologies, Inc. (A)vs ›$38.41B3.66%3.46%3.39%3.18%
Medline Inc. (MDLN)vs ›$32.87B3.11%3.21%3.21%3.21%

Earnings Yield vs P/E Ratio

Earnings Yield

2.07%

EPS ÷ Price

P/E Ratio

48.3

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield FAQ

What is the earnings yield for Edwards Lifesciences Corporation (EW)?
The earnings yield for EW stock is 2.07%.
Is Edwards Lifesciences Corporation's earnings yield high or low?
The earnings yield of 2.07% is 48% below its 5-year average of 3.98%, near the low end of its 5-year range (1.21%–10.54%).
What is the TTM average earnings yield for Edwards Lifesciences Corporation (EW)?
The TTM average earnings yield for EW stock is 4.84%.
What is the 3Y average earnings yield for Edwards Lifesciences Corporation (EW)?
The 3Y average earnings yield for EW stock is 5.01%.
What is the 5Y average earnings yield for Edwards Lifesciences Corporation (EW)?
The 5Y average earnings yield for EW stock is 2.65%.
What is the 10Y average earnings yield for Edwards Lifesciences Corporation (EW)?
The 10Y average earnings yield for EW stock is 2.36%.
What is the 15Y average earnings yield for Edwards Lifesciences Corporation (EW)?
The 15Y average earnings yield for EW stock is 2.50%.
What is the 20Y average earnings yield for Edwards Lifesciences Corporation (EW)?
The 20Y average earnings yield for EW stock is 3.02%.

EW Earnings Yield History

DATEEARNINGS YIELD
2026-06-262.07%
2026-06-252.10%
2026-06-242.10%
2026-06-232.16%
2026-06-222.19%
2026-06-182.15%
2026-06-172.17%
2026-06-162.12%
2026-06-152.18%
2026-06-122.21%
2026-06-112.19%
2026-06-102.19%
2026-06-092.15%
2026-06-082.19%
2026-06-052.19%
2026-06-042.15%
2026-06-032.19%
2026-06-022.14%
2026-06-012.13%
2026-05-292.17%
2026-05-282.19%
2026-05-272.17%
2026-05-262.15%
2026-05-222.19%
2026-05-212.26%
2026-05-202.27%
2026-05-192.29%
2026-05-182.28%
2026-05-152.31%
2026-05-142.31%
2026-05-132.31%
2026-05-122.36%
2026-05-112.44%
2026-05-082.35%
2026-05-072.27%
2026-05-062.26%
2026-05-052.21%
2026-05-042.20%
2026-05-012.18%
2026-04-302.19%
2026-04-292.25%
2026-04-282.22%
2026-04-272.19%
2026-04-242.17%
2026-04-232.30%
2026-04-222.24%
2026-04-212.30%
2026-04-202.25%
2026-04-172.26%
2026-04-162.31%
2026-04-152.34%
2026-04-142.34%
2026-04-132.34%
2026-04-102.35%
2026-04-092.31%
2026-04-082.24%
2026-04-072.26%
2026-04-062.25%
2026-04-022.26%
2026-04-012.25%
2026-03-312.29%
2026-03-302.30%
2026-03-272.31%
2026-03-262.23%
2026-03-252.21%
2026-03-242.24%
2026-03-232.23%
2026-03-202.22%
2026-03-192.22%
2026-03-182.22%
2026-03-172.17%
2026-03-162.19%
2026-03-132.24%
2026-03-122.16%
2026-03-112.15%
2026-03-102.13%
2026-03-092.17%
2026-03-062.24%
2026-03-052.18%
2026-03-042.15%
2026-03-032.15%
2026-03-022.10%
2026-02-272.12%
2026-02-262.13%
2026-02-252.19%
2026-02-242.82%
2026-02-232.81%
2026-02-202.91%
2026-02-192.94%
2026-02-182.94%
2026-02-172.96%
2026-02-133.06%
2026-02-123.03%
2026-02-112.92%
2026-02-103.01%
2026-02-093.02%
2026-02-062.95%
2026-02-052.97%
2026-02-042.91%
2026-02-032.83%
2026-02-022.81%
2026-01-302.85%
2026-01-292.85%
2026-01-282.83%
2026-01-272.78%
2026-01-262.75%
2026-01-232.77%
2026-01-222.75%
2026-01-212.72%
2026-01-202.78%
2026-01-162.75%
2026-01-152.75%
2026-01-142.79%
2026-01-132.77%
2026-01-122.79%
2026-01-092.73%
2026-01-082.74%
2026-01-072.74%
2026-01-062.70%
2026-01-052.76%
2026-01-022.72%
2025-12-312.72%
2025-12-302.69%
2025-12-292.67%
2025-12-262.67%
2025-12-242.69%
2025-12-232.69%
2025-12-222.68%
2025-12-192.71%
2025-12-182.74%
2025-12-172.73%
2025-12-162.72%
2025-12-152.78%
2025-12-122.79%
2025-12-112.75%
2025-12-102.76%
2025-12-092.79%
2025-12-082.75%
2025-12-052.69%
2025-12-042.70%
2025-12-032.76%
2025-12-022.74%
2025-12-012.72%
2025-11-282.68%
2025-11-262.67%
2025-11-252.67%
2025-11-242.74%
2025-11-212.73%
2025-11-202.76%
2025-11-192.70%
2025-11-182.76%
2025-11-172.74%
2025-11-142.69%
2025-11-132.69%
2025-11-122.71%
2025-11-112.72%
2025-11-102.76%
2025-11-072.78%
2025-11-062.81%
2025-11-052.80%
2025-11-048.26%
2025-11-038.37%
2025-10-318.43%
2025-10-308.33%
2025-10-298.40%
2025-10-288.45%
2025-10-278.60%
2025-10-249.13%
2025-10-239.08%
2025-10-229.04%
2025-10-219.14%
2025-10-209.23%
2025-10-179.31%
2025-10-169.57%
2025-10-159.53%
2025-10-149.47%
2025-10-139.52%
2025-10-109.40%
2025-10-099.24%
2025-10-089.17%
2025-10-079.06%
2025-10-069.07%
2025-10-039.02%
2025-10-029.07%
2025-10-019.11%
2025-09-308.94%
2025-09-299.00%
2025-09-269.12%
2025-09-259.23%
2025-09-249.31%
2025-09-239.32%
2025-09-229.43%
2025-09-199.34%
2025-09-189.32%
2025-09-179.24%
2025-09-169.26%
2025-09-159.14%
2025-09-128.96%
2025-09-118.91%
2025-09-108.88%
2025-09-098.71%
2025-09-088.67%
2025-09-058.58%
2025-09-048.58%
2025-09-038.55%
2025-09-028.50%
2025-08-298.55%
2025-08-288.55%
2025-08-278.59%
2025-08-268.55%
2025-08-258.60%
2025-08-228.50%
2025-08-218.56%
2025-08-208.54%
2025-08-198.80%
2025-08-188.87%
2025-08-158.88%
2025-08-148.89%
2025-08-138.94%
2025-08-129.03%
2025-08-118.89%
2025-08-088.87%
2025-08-078.92%
2025-08-068.84%
2025-08-058.83%
2025-08-048.74%
2025-08-018.83%
2025-07-318.83%
2025-07-308.63%
2025-07-298.70%
2025-07-288.92%
2025-07-258.75%
2025-07-249.23%
2025-07-239.10%
2025-07-229.17%
2025-07-219.14%
2025-07-189.15%
2025-07-179.19%
2025-07-169.19%
2025-07-159.12%
2025-07-148.94%
2025-07-118.97%
2025-07-108.88%
2025-07-099.07%
2025-07-089.17%
2025-07-079.12%
2025-07-039.12%
2025-07-029.09%
2025-07-019.07%
2025-06-308.95%
2025-06-278.95%
2025-06-269.07%
2025-06-259.09%
2025-06-249.23%
2025-06-239.29%
2025-06-209.48%
2025-06-189.46%
2025-06-179.55%
2025-06-169.35%
2025-06-139.31%

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

Related Metrics

P/E RatioFCF YieldDividend YieldAll Metrics

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Irvine, CA
15,800 employees
www.edwards.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian
View full financials